Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 30;19(1):363.
doi: 10.3390/ijerph19010363.

New Evidence on Regucalcin, Body Composition, and Walking Ability Adaptations to Multicomponent Exercise Training in Functionally Limited and Frail Older Adults

Jorge Pérez-Gómez  1 , Pedro C Redondo  2 , David Navarrete-Villanueva  3   4 , Gabriel Lozano-Berges  3   4 , Ignacio Ara  5   6 , Marcela González-Gross  7   8 , José A Casajus  3   4 , Germán Vicente-Rodríguez  3   4
Affiliations

New Evidence on Regucalcin, Body Composition, and Walking Ability Adaptations to Multicomponent Exercise Training in Functionally Limited and Frail Older Adults

Jorge Pérez-Gómez et al. Int J Environ Res Public Health. .

Abstract

Background: Regucalcin, or senescence marker protein-30 (SMP30), is a Ca2+-binding protein with multiple functions reported in the literature. Physical exercise has been shown to improve aging markers; nevertheless, SMP30 in humans has not been extensively researched. Older adults experience a decline in functional capacity and body composition. The purpose of this study was to examine the effects of a multicomponent training (MCT) program on SMP30 and its regulation of walking ability and body composition in functionally limited, frail, and pre-frail older adults.

Methods: A total of 34 older adults (aged 80.3 ± 6.1 years) were divided into an intervention group (IG = 20) and control group (CG = 14). The IG performed a supervised MCT (strength, endurance, balance, coordination, and flexibility) program for 6 months, 3 days per week, whereas the CG continued their normal lives without any specific physical training. SMP30 was analyzed in plasma after 3 and 6 months of MCT, while some physical fitness variables (Timed Up and Go (TUG) and 6-min walk test (6MWT)) and body composition (fat mass and lean mass) were measured at baseline, as well as after 3 months and 6 months of MCT.

Results: No significant changes were observed in SPM30 between the IG (877.5 a.u. to 940.5 a.u., respectively) and CG (790.4 a.u. to 763.8 a.u., respectively). Moreover, no SMP30 differences were found between groups after 3 and 6 months of MCT. The IG improved significantly in the 6MWT after 3 months (472.2 ± 84.2 m) compared to baseline (411.2 ± 75.2 m). The IG also significantly enhanced their TUG performance after 3 months (7.6 ± 1.6 s) and 6 months (7.3 ± 1.8 s) of training compared to baseline (9.3 ± 3.2 s) (all, p < 0.001). There were no significant differences in body composition between the IG and CG through the 6 months of MCT.

Conclusions: The present study suggests that MCT did not change SMP30 levels from 3 to 6 months, where there were changes in neither walking ability nor body composition; however, MCT was effective in improving 6MWT and TUG performance from baseline to 3 months.

Keywords: endurance training; human; physical exercise; physical fitness; strength training.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Elies J., Yanez M., Pereira T.M.C., Gil-Longo J., MacDougall D.A., Campos-Toimil M. An Update to Calcium Binding Proteins. Adv. Exp. Med. Biol. 2020;1131:183–213. doi: 10.1007/978-3-030-12457-1_8. - DOI - PubMed
    1. Fujita T., Inoue H., Kitamura T., Sato N., Shimosawa T., Maruyama N. Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells. Biochem. Biophys. Res. Commun. 1998;250:374–380. doi: 10.1006/bbrc.1998.9327. - DOI - PubMed
    1. Yamaguchi M. Role of regucalcin in brain calcium signaling: Involvement in aging. Integr. Biol. 2012;4:825–837. doi: 10.1039/c2ib20042b. - DOI - PubMed
    1. Yamaguchi M., Murata T. Involvement of regucalcin in lipid metabolism and diabetes. Metabolism. 2013;62:1045–1051. doi: 10.1016/j.metabol.2013.01.023. - DOI - PubMed
    1. Tsurusaki Y., Yamaguchi M. Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J. Cell. Biochem. 2003;90:619–626. doi: 10.1002/jcb.10652. - DOI - PubMed

Publication types